[1]刘高仁,李 鲜.温阳利水汤对急性心力衰竭合并1型心肾综合征患者心肾功能保护效应[J].陕西中医,2019,(4):462-465.
　LIU Gaoren,LI Xian..Protective effect of Wenyang Lishui decoction on cardiac and renal function in patients with acute heart failure complicated with type 1 cardiorenal syndrome[J].,2019,(4):462-465.
点击复制

温阳利水汤对急性心力衰竭合并1型心肾综合征患者心肾功能保护效应
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年4期
页码:
462-465
栏目:
临床研究
出版日期:
2019-04-05

文章信息/Info

Title:
Protective effect of Wenyang Lishui decoction on cardiac and renal function in patients with acute heart failure complicated with type 1 cardiorenal syndrome
文章编号:
DOI:10.3969/j.issn.10007369.2019.04.017
作者:
刘高仁; 李 鲜
河南省中医院急诊科（郑州 450002）
Author(s):
LIU Gaoren; LI Xian.
Department of Emergency，Henan Province Hospital of TCM （Zhengzhou 450002）
关键词:
温阳利水汤; 急性心力衰竭; 心肾综合征; 心功能; 肾功能; 保护效应
Keywords:
Key words Wenyang Lishui decoction; Acute heart failure; Cardiorenal syndrome; Cardiac function; Renal function ; Protective effect
分类号:
R541.61
文献标志码:
A
摘要:
摘 要 目的：观察温阳利水汤对急性心力衰竭(AHF)合并1型心肾综合征(CRS)患者心肾功能保护效应。方法：将90例AHF合并1型CRS患者随机分为观察组(n=45)和对照组(n=45)，对照组给予常规西医治疗，观察组在对照组的基础上给予温阳利水汤治疗，疗程2周。统计两组临床疗效；观察两组治疗前后中医症状积分、心肾功能和相关生化检查指标的变化。结果：观察组临床疗效显著优于对照组(P＜0.05)；两组治疗后中医症状单项(胸闷、心悸、气喘、水肿、尿量减少、形寒肢冷、倦怠乏力)积分与总积分均显著降低，观察组治疗后以上积分均低于对照组(P＜0.05)；两组治疗后LVEF、FS、LVEDD、E/A、CO和CI均显著改善，观察组治疗后以上指标均优于对照组(P＜0.05)。两组治疗后Cr、BUN、MAU、eGFR和尿量均显著改善，观察组治疗后以上指标均优于对照组(P＜0.05)。两组治疗后血清hsCRP、Hcy和NTproBNP均显著降低，观察组治疗后以上指标均低于对照组(P＜0.05)。结论：温阳利水汤可改善AHF合并1型CRS患者临床症状，提高临床疗效，具有显著的心肾保护效应，其机制可能与其下调血清hsCRP、DD和NTproBNP表达有关。
Abstract:
Abstract Objective ：To observe the protective effect of Wenyang Lishui decoction on cardiac and renal function in patients with acute heart failure (AHF) complicated with type 1 cardiorenal syndrome (CRS). Methods ：90 cases of AHF patients with type 1 CRS were randomly divided into the observation group (n=45) and the control group (n=45). The control group was treated with conventional western medicine. Statistics of clinical efficacy of the two groups；Changes in TCM symptom score，cardiac and renal function and related biochemical parameters were observed before and after treatment in the two groups. Results： the clinical efficacy of the observation group was significantly better than that of the control group (P＜0.05). After treatment，the single item of TCM symptoms (chest tightness，palpitation，asthma，edema，reduced urine volume，cold body shape，fatigue and weakness) and the total score of the two groups were significantly reduced，and the above score of the observation group was lower than that of the control group (P＜0.05). After treatment，LVEF，FS，LVEDD，E/A，CO and CI were significantly improved in both groups，and the above indicators in the observation group were better than those in the control group (P＜0.05). Cr，BUN，MAU，eGFR and urine volume were significantly improved after treatment in both groups，and the indicators above in the observation group were better than those in the control group (P＜0.05). The serum hscrp，Hcy and ntprobnp of the two groups were significantly decreased after treatment，and the above indexes of the observation group were lower than those of the control group (P＜0.05). Conclusion： Wenyang Lishui decoction can improve the clinical symptoms and clinical efficacy of AHF combined with type 1 CRS patients，and has significant cardiorenal protective effect. The mechanism may be related to the downregulation of the expression of serum hscrp，dd and NTproBNP.

参考文献/References:

[1] 肖莉丽，上官佳红，陈 阳，等. 急性左心衰竭患者发生I型心肾综合征的相关危险因素分析 [J]. 中国现代医学杂志，2017，27(25):8387.
[2] 汪雁博，傅向华. 1型心肾综合征病理生理学机制研究进展 [J]. 中华临床医师杂志：电子版，2016，25(1):9699.
[3] 中华医学会心血管病学分会. 中国心力衰竭诊断和治疗指南2014 [J]. 中华心血管病杂志，2014，42(2):310.
[4] Prins K W，Thenappan T，Markowitz J S，et al. Cardiorenal Syndrome Type 1：Renal Dysfunction in Acute Decompensated Heart Failure [J]. J Clin Outcomes Manag，2015，22(10):443454.
[5] 国家中医药管理局. 中医病证诊断疗效标准 [M]. 南京:南京大学出版社，1994:234235.
[6] 陈昱文，曹泽标，周小青，等. 中医症状量化方法及其临床应用述评 [J]. 湖南中医药大学学报，2016，36(3):8286.
[7] 骆雷鸣. 心肾间交互作用与急性心力衰竭时肾功能恶化的关系 [J]. 中国全科医学，2017，20(9):10191024.
[8] 徐建国，徐 敏，李 钰，等. 氨基末端B型利钠肽前体联合胱抑素C在1型心肾综合征早期诊断中的应用价值 [J]. 中华急诊医学杂志，2015，24(5):518523.
[9] 杨雪卿，李雪峰，王 显. 心肾综合征炎症机制的研究进展 [J]. 中国循证心血管医学杂志，2012，4(4):383385.〖ZK)〗
[10] 王 淼，张 强，王义围，等. 老年患者射血分数保留心力衰竭与N端脑钠肽前体、超敏C反应蛋白、血尿酸及同型半胱氨酸的相关性 [J]. 中国老年学杂志，2017，37(2):366368.
[11] 孙佳鹏，肖慧捷，丁 洁. 同型半胱氨酸:心肾损伤的共同标志之一 [J]. 中华实用儿科临床杂志，2015，30(17):13551357.
[12] 董 艳，王 阶. 心肾综合征以传统“心肾相关”思路论治探讨 [J]. 中国中西医结合杂志，2017，37(10):12541257.
[13] 黄海燕，尚 峰，袁宏伟. Ⅰ型心肾综合征中西医研究及治疗进展 [J]. 中西医结合心脑血管病杂志，2017，15(20):25642566.
[14] 黄小驰，刘 莹. 心肾综合征的分级、发病机制及中西医结合治疗进展 [J]. 辽宁中医药大学学报，2016，18(3):218221.
[15] 徐菲拉，颜 梅，何忠平. 附子与人参配伍对心衰大鼠IL10、IL18、TNFα表达水平的影响 [J]. 中华中医药学刊，2016，35(5):12331236.
[16] 刘 威，刘 辉，艾雅青. 丹参粉针联合左卡尼汀对缺血性心力衰竭的疗效及其对肾功能损害的影响 [J]. 中国急救复苏与灾害医学杂志，2015，10(1):3336.
[17] 柴连海，王丽丽，陈文生. 黄芪及其活性成分黄芪多糖对心衰模型小鼠同型半胱氨酸、核因子κB和D二聚体水平的影响 [J]. 中国实验方剂学杂志，2015，21(17):142145. \[18\] 张福港，卞书森. 黄芪注射液配合西药治疗原发性肾病综合征临床研究 [J]. 陕西中医，2016，37(8):10271028.

更新日期/Last Update: 2019-04-24